Keymed Biosciences Inc.
HKEX:2162.HK
Overview | Financials
Company Name | Keymed Biosciences Inc. |
Symbol | 2162.HK |
Currency | HKD |
Price | 43.55 |
Market Cap | 12,002,380,000 |
Dividend Yield | 0% |
52-week-range | 26.6 - 64.45 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Bo Chen |
Website | https://www.keymedbio.com |
An error occurred while fetching data.
About Keymed Biosciences Inc.
Keymed Biosciences Inc., a biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases. Its lead product candidate is CM310 for the treatment of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD